ID   UKWMPi002-A-2
AC   CVCL_A4YE
SY   CDH13-/- iPSC
DR   hPSCreg; UKWMPi002-A-2
DR   Wikidata; Q107117239
RX   PubMed=33486346;
CC   From: Division of Molecular Psychiatry, Center of Mental Health, University of Wurzburg; Wurzburg; Germany.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; 1753; CDH13.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A4YC ! UKWMPi002-A
SX   Female
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
RX   PubMed=33486346; DOI=10.1016/j.scr.2021.102169;
RA   Vitale M.R., Zoller J.E.M., Jansch C., Janz A., Edenhofer F.,
RA   Klopocki E., van den Hove D., Vanmierlo T., Rivero O., Nadif Kasri N.,
RA   Ziegler G.C., Lesch K.-P.;
RT   "Generation of induced pluripotent stem cell (iPSC) lines carrying a
RT   heterozygous (UKWMPi002-A-1) and null mutant knockout (UKWMPi002-A-2)
RT   of cadherin 13 associated with neurodevelopmental disorders using
RT   CRISPR/Cas9.";
RL   Stem Cell Res. 51:102169-102169(2021).
//